Correlation Between Penumbra and Vivos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Penumbra and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Penumbra and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Penumbra and Vivos Therapeutics, you can compare the effects of market volatilities on Penumbra and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Penumbra with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Penumbra and Vivos Therapeutics.
Diversification Opportunities for Penumbra and Vivos Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Penumbra and Vivos is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Penumbra and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Penumbra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Penumbra are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Penumbra i.e., Penumbra and Vivos Therapeutics go up and down completely randomly.
Pair Corralation between Penumbra and Vivos Therapeutics
Considering the 90-day investment horizon Penumbra is expected to under-perform the Vivos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Penumbra is 17.07 times less risky than Vivos Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Vivos Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,100 in Vivos Therapeutics on September 4, 2024 and sell it today you would lose (734.00) from holding Vivos Therapeutics or give up 66.73% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Penumbra vs. Vivos Therapeutics
Performance |
Timeline |
Penumbra |
Vivos Therapeutics |
Penumbra and Vivos Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Penumbra and Vivos Therapeutics
The main advantage of trading using opposite Penumbra and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Penumbra position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.Penumbra vs. Insulet | Penumbra vs. TransMedics Group | Penumbra vs. Masimo | Penumbra vs. Inspire Medical Systems |
Vivos Therapeutics vs. Baxter International | Vivos Therapeutics vs. West Pharmaceutical Services | Vivos Therapeutics vs. ResMed Inc | Vivos Therapeutics vs. The Cooper Companies, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |